With the analysis among 14,238 patents, we discovered top 450 key players by total patent application. Novartis AG, Galapagos NV, Bristol Myers Squibb Co. are dominant in this area. They take 22.19% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 2,270
New York, United States
Patent: 443
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 394
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 321
New Jersey, United States
Patent: 297
California, United States
Patent: 260
New Jersey, United States
Patent: 259
New Jersey, United States
Patent: 252
California, United States
Patent: 193
With the analysis among 267 patents, we discovered top 39 start-ups by total patent application. Capella Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Shenzhen Tajirui Biomedical Co. Ltd. are active in this area.
Capella Therapeutics, Inc.
California, United States
Patent: 39
Institut National de la Santé et de la Recherche Médicale
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 23
Bayern, Germany
Patent: 22
California, United States
Patent: 16
Argonaut Therapeutics Ltd.
Intarcia Therapeutics, Inc.
California, United States
Patent: 10
Massachusetts, United States
Patent: 8
With the analysis among related 2,003 patents applied in the last 5 years. We discover 354 most active companies in this area. The fast-growing Dana-Farber Cancer Institute, Inc., Galapagos NV, Novartis AG take 19.77% of patent filing during this period.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 165
Basel-Stadt, Switzerland
Patent: 102
Syros Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 49
Nordrhein-Westfalen, Germany
Patent: 31
California, United States
Patent: 30
The Board of Regents of The University of Texas System
Texas, United States
Patent: 30
Berlin, Germany
Patent: 27
Hessen, Germany
Patent: 26
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Shanghai Shi, China
Patent: 25
With the analysis among related 2,003 patents in last 5 years, we discover 164 new entrants. Qilu Pharmaceutical Co., Ltd., MiroBio Ltd., LegoChem Biosciences, Inc. are the most active new entrants in this area.
Qilu Pharmaceutical Co., Ltd.
Shandong Sheng, China
Patent: 23
LegoChem Biosciences, Inc.
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 18
Nippon Shinyaku Co., Ltd.
Kyoto-fu, Japan
Patent: 16
California, United States
Patent: 16
Argonaut Therapeutics Ltd.
Actinium Pharmaceuticals, Inc.
New York, United States
Patent: 13
Constellation Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 11
With the analysis among 2,133 patents, we discovered top 219 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Massachusetts Institute of Technology, Yale University are dominant in this area. They take 15.14% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 105
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 70
Connecticut, United States
Patent: 39
The Johns Hopkins University
Korea Institute of Science & Technology
The University of Sheffield
SHEFFIELD, United Kingdom
Patent: 28
Birmingham, United Kingdom
Patent: 28
Regents of the University of Colorado
Colorado, United States
Patent: 28
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 25